Stopped: study withdrawn, no participant enrolled, change in the study design planned
This study design is a prospective randomized control trial to compare outcomes between the utilization of coronary computed tomography angiography (CCTA) vs conservative treatment in type 2 NSTEMI. The targeted population is expectedly heterogeneous and inpatient setting who are admitted and diagnosed with type 2 NSTEMI.
Age range
18 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
MACE
Timeframe: anytime within 3 years
Cardiovascular (CV) mortality
Timeframe: anytime within 3 years
Nonfatal MI, stroke
Timeframe: anytime within 3 years
Hospitalization for unstable angina
Timeframe: anytime within 3 years
Hospitalization for heart failure
Timeframe: anytime within 3 years
Unplanned revascularization
Timeframe: anytime within 3 years